RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
This Quarter Return
+10.77%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$4.58B
AUM Growth
+$4.58B
(-2.1%)
Cap. Flow
+$43.2M
Cap. Flow
% of AUM
0.94%
Top 10 Holdings %
Top 10 Hldgs %
23.53%
Holding
172
New
18
Increased
60
Reduced
32
Closed
20
Top Buys
| 1 |
Immunocore
IMCR
|
$97.6M |
| 2 |
FPRX
Five Prime Therapeutics, Inc.
FPRX
|
$73M |
| 3 |
Bolt Biotherapeutics
BOLT
|
$51.3M |
| 4 |
Cullinan Oncology
CGEM
|
$44.8M |
| 5 |
AstraZeneca
AZN
|
$32.3M |
Top Sells
| 1 |
Neurocrine Biosciences
NBIX
|
$54.5M |
| 2 |
UnitedHealth
UNH
|
$48.4M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$47.9M |
| 4 |
Centene
CNC
|
$43.8M |
| 5 |
Immunovant
IMVT
|
$41.2M |
Sector Composition
| 1 | Healthcare | 93.74% |
| 2 | Consumer Staples | 1.75% |
| 3 | Industrials | 0.62% |
| 4 | Financials | 0.12% |
| 5 | Consumer Discretionary | 0% |
